Clinical Evaluation of Terap C Vaccine Candidate in Combined Treatment with Interferon and Ribavirin in Patients with Hepatitis C
Conclusions: Vaccination with Terap C in patients with chronic HCV infection was safe and well tolerated.
Source: Current Therapeutic Research - Category: Drugs & Pharmacology Source Type: research
More News: Chronic Pain | Clinical Trials | Drugs & Pharmacology | Gastroenterology | Headache | Hepatitis | Hepatitis C | Hepatitis Vaccine | Immunotherapy | Migraine | Pain | Psychiatry | Study | Vaccines | Virology